Management Approach
Bora Group is committed to sustainable operations, with “Contributing to Better Health All Over The World” as its core mission. A robust and responsible supply chain is fundamental to drug quality, process stability, and sustainable development. The Group aligns its supplier management approach with international standards, including the UN Sustainable Development Goals (SDGs), the UN Global Compact (UNGC), and the Pharmaceutical Supply Chain Initiative (PSCI), and establishes a three-tier supplier management framework: the “Bora Group Supplier Code of Conduct” as the core guiding principle, the “Supplier Sustainability Self-Assessment Form” as the implementation mechanism, extending to five key areas — Business Ethics, Labor Rights, Health and Safety, Environmental Management, and Governance & Management Systems.
As a leading pharmaceutical company based in Taiwan, Bora operates across both Pharma Sales and CDMO sectors under a dual operating model that calls for differentiated supplier strategies. The Pharma Sales business depends on a defined set of active pharmaceutical ingredients (APIs) and intermediates, and pursues a global, multi-source procurement strategy across the United States, India, Germany, and Japan, anchored in GMP and ISO 9001 certification. The CDMO business centers on customized manufacturing services with APIs typically supplied by customers; company-procured materials are predominantly excipients, packaging, and general-purpose inputs, and suppliers exceeding NT$1 million in annual purchases or designated as strategic undergo an annual performance evaluation covering price, quality, delivery, service, and green chemistry practices.
Supplier Management Approach
Bora ensures supply stability and sustainability through a diversification strategy- engaging, at least 2 interchangeable, competitive suppliers for critical materials and services to mitigate risks and control costs.
Supplier Selection Criteria Include：
- Quality certifications (e.g., GMP, GLP, GDP, ISO 9001, ISO 13485, ISO 17025).
- On-site audit results and third-party inspection records.
- Annual quality reviews, regular document updates, and audits.
We also assess suppliers’ process capabilities, product quality, on-time delivery performance, and collaboration through supplier self-assessment questionnaires, document reviews, and site audits. These efforts are meant to strengthen partnerships and create value.
New Supplier Management
New suppliers undergo a structured 8-stage qualification process before approval: baseline review and quotation, supplier basic information and document review, sample testing and evaluation, formal evaluation and audit, scope definition, sample testing, information gathering via questionnaire, and finance and contract review. Suppliers who pass are listed in the Qualified Supplier List and undergo regular quality reviews and document re-evaluations. All suppliers are screened against U.S. FDA classification standards to ensure no high-risk manufacturers enter our supply chain.
Supply Chain Review Methods
Bora Group implements a lifecycle management mechanism spanning new-supplier qualification, ongoing monitoring, and performance evaluation. Existing suppliers undergo formal evaluations based on internal quality management and sustainability standards, including document review and necessary on-site audits, covering the quality system, product stability, on-time delivery rate, and ESG performance, with results stored in an internal shared database. Starting Q1 2026, Taiwan sites will fully implement a 100-point “comprehensive, routine performance evaluation” for MRO suppliers whose transaction value exceeds NT$1 million at a single site or NT$3 million across sites. Based on the weighted score of operating and ESG performance, suppliers are categorized into three tiers: Tier A (100-85 points, priority partners), Tier B (84-70 points, general partners), and Tier C (69-60 points, watch list requiring CAPA).
